Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Pediatric Asthma: A Prospective Study in 68 Children Aged 7 Years

MLA

Julie Magnier, et al. “Soluble Receptor of Advanced Glycation End-Products (SRAGE) in Pediatric Asthma: A Prospective Study in 68 Children Aged 7 Years.” Applied Sciences, vol. 12, no. 12, June 2022, p. 5926. EBSCOhost, https://doi.org/10.3390/app12125926.

APA

Julie Magnier, Valérie Julian, Vincent Sapin, Aurélien Mulliez, Alexandra Usclade, Emmanuelle Rochette, Bertrand Evrard, André Labbe, Karen Coste, & Carole Egron. (2022). Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Pediatric Asthma: A Prospective Study in 68 Children Aged 7 Years. Applied Sciences, 12(12), 5926. https://doi.org/10.3390/app12125926

Chicago

Julie Magnier, Valérie Julian, Vincent Sapin, Aurélien Mulliez, Alexandra Usclade, Emmanuelle Rochette, Bertrand Evrard, André Labbe, Karen Coste, and Carole Egron. 2022. “Soluble Receptor of Advanced Glycation End-Products (SRAGE) in Pediatric Asthma: A Prospective Study in 68 Children Aged 7 Years.” Applied Sciences 12 (12): 5926. doi:10.3390/app12125926.